20230913230105_65023f3108ee9_nr_507_week_case_study__alzheimer__discussion.docx
20230913230105_65023f3108ee9_nr_507_week_case_study__alzheimer__discussion.docx
NR 507 Week 7
Compare and contrast the pathophysiology between Alzheimer's disease and
frontotemporal dementia.
Alzheimer's disease and frontotemporal dementia are both neurodegenerative diseases
that result in progressive cognitive decline. Alzheimer's disease is the most common form of
dementia and is characterized by the accumulation of abnormal proteins and the loss of neurons
in the brain. The primary cause of neuronal loss is abnormal amyloid beta and tau protein
deposits (Kumar et al.,2022). These proteins are found in the hippocampus, an area of the brain
responsible for memory, and cause the nerve cells in that area to become damaged and
eventually die. As the neurons die, the hippocampus shrinks, resulting in a loss of memory and
cognitive abilities (Knopman et al., 2021). In contrast, frontotemporal dementia is caused by the
degeneration of neurons in the frontal and temporal lobes of the brain (McCance & Huether,
2019). These brain areas are responsible for higher-order functions such as language, behavior,
and decision-making. As these neurons degenerate, the patient experiences a decline in their
ability to communicate and changes in their personality and behavior. While both diseases have a
similar end result, their causes and symptoms differ. Alzheimer's disease is caused by the
accumulation of abnormal proteins which damage the neurons in the hippocampus, resulting in a
loss of memory and cognitive abilities. In contrast, frontotemporal dementia is caused by the
degeneration of neurons in the frontal and temporal lobes of the brain, resulting in a decline in
language and communication, as well as changes in behavior and personality (McCance &
Huether, 2019).
20230913230105_65023f3108ee9_nr_507_week_case_study__alzheimer__discussion.docx
20230913230105_65023f3108ee9_nr_507_week_case_study__alzheimer__discussion.docx
20230913230105_65023f3108ee9_nr_507_week_case_study__alzheimer__discussion.docx
, 20230913230105_65023f3108ee9_nr_507_week_case_study__alzheimer__discussion.docx
20230913230105_65023f3108ee9_nr_507_week_case_study__alzheimer__discussion.docx
20230913230105_65023f3108ee9_nr_507_week_case_study__alzheimer__discussion.docx
2. Identify the clinical findings from the case that supports a diagnosis of
Alzheimer's disease.
Based on the clinical presentation and diagnostic findings, the patient was diagnosed with
Alzheimer's type dementia. Specifically, the patient presented with several symptoms consistent
with Alzheimer's disease, including memory loss, difficulty with decision-making, difficulty
dressing, and disorientation. Additionally, the patient's PMH was significant for a family history
of Alzheimer's, as his father had passed away due to a decline associated with the disease.
Furthermore, the Mini-Mental State Examination (MMSE) results revealed a baseline score of 12
out of 30, indicating moderate dementia. Lastly, the MRI revealed hippocampal atrophy, a
hallmark of Alzheimer's disease. These findings all support a diagnosis of Alzheimer's type
dementia.
3. Explain one hypothesis that explains the development of Alzheimer's disease
One hypothesis that explains the development of Alzheimer's disease is known as the
amyloid cascade hypothesis. This hypothesis suggests that the accumulation of a protein known
as an amyloid beta in the brain is responsible for the development of Alzheimer's disease.
Amyloid beta is produced in small amounts and is typically cleared away by the body's natural
processes. However, in cases of Alzheimer's disease, the amyloid beta is not cleared away and
instead accumulates in the brain. This accumulation of amyloid beta is thought to destroy
neurons and cause other neurological damage, which leads to the development of Alzheimer's
disease. The accumulation of amyloid beta is thought to be caused by a combination of genetic
and environmental factors. It is believed that certain genetic variations cause the body to be less
effective at clearing away the amyloid beta, thus leading to its accumulation in the brain.
Environmental factors such as exposure to certain toxins or infections may also contribute to the
20230913230105_65023f3108ee9_nr_507_week_case_study__alzheimer__discussion.docx
20230913230105_65023f3108ee9_nr_507_week_case_study__alzheimer__discussion.docx
20230913230105_65023f3108ee9_nr_507_week_case_study__alzheimer__discussion.docx